Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$1.04 - $1.5 $93,600 - $135,000
-90,000 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$0.84 - $2.16 $512,400 - $1.32 Million
-610,000 Reduced 87.14%
90,000 $105,000
Q4 2020

Feb 16, 2021

BUY
$0.65 - $1.11 $455,000 - $777,000
700,000 New
700,000 $601,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Saltoro Capital, LP Portfolio

Follow Saltoro Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saltoro Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Saltoro Capital, LP with notifications on news.